AbCellera ( $ABCL )

Recent earnings result

1. AbCellera Biologics EPS misses by $0.14, beats on revenue

Events & Annual meetings

There are no events at this time for this stock.

For list of ABCL events, you may visit their Investor Relations website.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, AI-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.

For list of ABCL events, you may visit their Investor Relations website.

Recent results

• $LFMD - LifeMD
  

  LifeMD EPS of -$2.56

• $PCVX - Vaxcyte Inc
  

  Vaxcyte EPS beats by $0.12

• $ABCL - AbCellera
  

  AbCellera Biologics EPS misses by $0.14, beats on revenue

• $VERO - Venus Concept
  

  Venus Concept EPS misses by $0.16, beats on revenue

• $VTSI - VirTra, Inc.
  

  VirTra EPS beats by $0.17, beats on revenue

• $SEER - Seer Inc
  

  Seer EPS misses by $0.41, beats on revenue

• $BIOC - Biocept Inc
  

  Biocept EPS beats by $0.41, beats on revenue

• $SRAX - Social Reality
  

  SRAX Q4 beats on revenue

• $ACTG - Acacia Research Corporation
  

  Acacia Research EPS beats by $1.47, beats on revenue

• $CALM - Cal-Maine Foods, Inc.
  

  Cal-Maine Foods EPS beats by $0.21, misses on revenue